346
Views
8
CrossRef citations to date
0
Altmetric
Review

Pharmacological treatment options for panic disorder in children and adolescents

, &
Pages 545-554 | Published online: 23 Mar 2006

Bibliography

  • AMERICAN PSYCHIATRIC ASSOCIATION: Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC (1994).
  • VON KORFF M, EATON W, KEYL P: The epidemiology of panic attacks and panic disorders: results of three community surveys. Am. J. Epidemiol. (1985) 122:970-981.
  • WEISSMANN MM, BLAND RC, CANINO GJ et al.: The cross-national epidemiology of panic disorder. Arch. Gen. Psychiatry (1997) 54:305-309.
  • KLEIN DF: Anxiety reconceptualized. In: Anxiety: new research and changing concepts. Klein DF, Rabkin J (Eds). Raven Press, New York (1981):235-263.
  • KLEIN DF, MANNUZZA S, CHAPMAN T, FYER A: Child panic revisited. J. Am. Acad. Child Adolesc. Psychiatry (1992) 31:112-116.
  • BLACK B, ROBBINS DR: Panic disorder in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry (1990) 29:36-44.
  • MOREAU D, WEISSMANN MM: Panic disorder in children and adolescents: a review. Am. J. Psychiatry (1992) 149:1306-1314.
  • HAYWARD C, KILLEN JD, HAMMER LD et al.: Pubertal stage and panic attack history in sixth- and seventh-grade girls. Am. J. Psychiatry (1992) 149:1239-1243.
  • GOODWIN RD, GOTLIB IH: Panic attacks and psychopathology among youth. Acta Psychiatr. Scand. (2004) 3:216-221.
  • WHITAKER A, JOHNSON J, SHAFFER D et al.: Uncommon troubles in young people: prevalence estimates of selected psychiatric disorders in a non-referred adolescent population. Arch. Gen. Psychiatry (1990) 47:487-496.
  • WITTCHEN HU, REED V, KESSLER RC: The relationship of agoraphobia and panic in a community sample of adolescents and young adults. Arch. Gen. Psychiatry (1998) 55:1017-1024.
  • ESSAU CA, CONDRADT J, PETERMANN F: Frequency of panic attacks and panic disorder in adolescents. Depress. Anxiety (1999) 9:19-26.
  • LAST CG, STRAUSS CC: Panic disorder in children and adolescents. J. Anxiety Disord. (1989) 3:87-95.
  • ALESSI NE, MAGEN J: Panic disorders in psychiatrically hospitalized children. Am. J. Psychiatry (1988) 145:1450-1452.
  • BIEDERMAN J, FARAONE SV, MARRS A et al.: Panic disorder and agoraphobia in consecutively referred children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry (1997) 36:214-223.
  • MASI G, FAVILLA L, MUCCI M, MILLEPIEDI S: Panic disorder in clinically referred children and adolescents. Child Psychiatry Hum. Dev. (2000) 31:139-151.
  • VITIELLO B, BEHAR D, WOLFSON S, MCLEER SV: Diagnosis of panic disorder in prepubertal children. J. Am. Acad. Child Adolesc. Psychiatry (1990) 29:782-784.
  • ALESSI NE, ROBBINS DR, DILSAVER SC: Panic and depressive disorders among psychiatrically hospitalized adolescents. Psychiatr Res. (1987) 20:275-283.
  • BALLENGER JC, CAREK DJ, STEELE DJ, CORNISH-MCFTIGHE D: Three cases of panic disorder with agoraphobia in children. Am. J. Psychiatry (1989) 146:922-924.
  • BIEDERMAN J: Clonazepam in the treatment of prepubertal children with panic-like symptoms. J. Clin. Psychiatry (1987) 48(Suppl.):38-42.
  • MOREAU DL, WEISSMANN MM, WARNER V: Panic disorder in children at high risk for depression. Am. J. Psychiatry (1989) 146:1059-1060.
  • BRADLEYS J, HOOD J: Psychiatrically referred adolescents with panic attacks: presenting symptoms, stressors and comorbidity. J. Am. Acad. Child Adolesc. Psychiatry (1993) 32:826-829.
  • DILER RS, BIRMAHER B, BRENT DA et al.: Phenomenology of panic disorder in youth. Depress. Anxiety (2004) 20:39-43.
  • NELLES WB, BARLOW DH: Do children panic? Clin. Psychol. Rev. (1988) 8:359-372.
  • MASI G, TONI C, MUCCI M et al.: Paroxetine in child and adolescent outpatients with panic disorder. J. Child Adolesc. Psychopharmacol. (2001) 11:151-157.
  • MASI G, MUCCI M, MILLEPIEDI S: Separation anxiety in children and adolescents: epidemiology, diagnosis and management. CNS Drugs (2001) 15:93-104.
  • GOODWIN R, LIPSITZ JD, CHAPMAN TF et al.: Obsessive-compulsive disorder and separation anxiety comorbidity in early-onset panic disorder. Psychol. Med. (2001) 31:1307-1310.
  • MASI G, MILLEPIEDI S, MUCCI M et al.: Generalized anxiety disorder in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry (2004) 43:752-760.
  • MASI G, MILLEPIEDI S, MUCCI M et al.: A naturalistic study of referred children and adolescents with obsessive-compulsive disorder. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44:673-681.
  • GOODWIN RD, FERGUSSON DM, HORWOOD LJ: Panic attacks and the risk of depression among young adults in the community. Psychother. Psychosom. (2004) 73:158-165.
  • MASI G, TONI C, PERUGI G et al.: Anxiety comorbidity in consecutively referred children and adolescents with bipolar disorder: a neglected comorbidity. Can. J. Psychiatry (2001) 46:766-771.
  • BIRMAHER B, KENNAH A, BRENT D et al.: Is bipolar disorder specifically associated with panic disorder youth? J. Clin. Psychiatry (2002) 41:414-419.
  • BATTAGLIA M, BERTELLA M, POLITI E et al.: Age of onset of panic disorder: influence of familial liability to the disease and of childhood separation anxiety disorder. Am. J. Psychiatry (1995) 152:1362-1364.
  • TOREN P, ELDAR S, CENDOR D et al.: The prevalence of mitral valve prolapse in children with anxiety disorders. J. Psychiatr. Res. (1999) 33:357-361.
  • BIEDERMAN J, ROSENBAUM JF, BOLDUC EA et al.: A high-risk study of young children of children of parents with panic disorder and agoraphobia with and without comorbid major depression. J. Psychiatr. Res. (1991) 37:333-348.
  • BIEDERMAN J, FARAONE SV, HIRSHFELD-BECKER D et al.: Patterns of psychopathology and dysfunction in high-risk children of parents with panic disorder and major depression. Am. J. Psychiatry (2001) 158:49-57.
  • HAYWARD C, WILSON KA, LAGLE K et al.: Parent-reported predictors of adolescent panic attacks. J. Am. Acad. Child Adolesc. Psychiatry (2004) 43:613-620.
  • ASCHENBRAND SG, KENDALL PC, WEBB A et al.: Is childhood separation anxiety disorder a predictor of adult panic disorder and agoraphobia? A seven-year longitudinal study. J. Am. Acad. Child Adolesc Psychatry (2003) 42:1478-1485.
  • BANDELOW B, ALVAREZ TICHAUER G, SPATH G et al.: Separation anxiety and actual separation experiences during childhood in patients with panic disorder. Can. J. Psychiatry (2001) 46:948-952.
  • ROSENBAUM JF, BIEDERMAN J, GERSTEN M et al.: Behavioral inhibition in children of parents with panic disorder and agoraphobia. Arch. Gen. Psychiatry (1988) 45:463-470.
  • ROSENBAUM JF, BIEDERMAN J, HIRSCHFELD DR et al.: Behavioral inhibition in children: a possible precursor to panic disorder or social phobia. J. Clin. Psychiatry (1991) 52(Suppl.):5-9.
  • ROSENBAUM JF, BIEDERMAN J, HIRSHFELD-BECKER DR et al.: A controlled study of behavioral inhibition in children of parents with panic disorder and depression. Am. J. Psychiatry (2000) 157:2002-2010.
  • BIEDERMAN J, ROSENBAUM JF, BOLDUC-MURPHY EA et al.: A 3-year follow-up of children with and without behavioral inhibition. J. Am. Acad. Child Adolesc. Psychiatry (1993) 32:814-821.
  • BANDELOW B, ZOHAR J, HOLLANDER E, KASPER S, MOLLER HJ: World Federation of Societies of Biol. Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders. World J. Biol. Psychiatry (2002) 3:171-199.
  • BALDWIN DS, ANDERSON IM, NUTT DJ et al.: Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association of Psychopharmacol. J. Psychopharmacol. (2005) 19:567-596.
  • MASI G, MILLEPIEDI S, MUCCI M: Efficacy of newer antidepressants for childhood anxiety disorders. Exp. Rev. Neurotherap. (2002) 2:89-97.
  • BRENT DA, POLING K, MCKAIN B, BAUGHER M: A psychoeducation program for families of affectively ill children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry (1993) 32:770-774.
  • WESTEN D, MORRISON K: A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. J. Consult. Clin. Psychol. (2001) 69:875-899.
  • OLLENDICK TH: Cognitive-behavioral treatment of panic disorder with agoraphobia in adolescents: a multiple baseline design analysis. Behav. Ther. (1995) 26:517-531.
  • VITIELLO B, JENSEN PS: Medication development and testing in children and adolescents. Arch. Gen. Psychiatry (1997) 54:871-876.
  • EMSLIE GJ, WALKUP JT, PLISZKA SR, ERNST M: Non tricyclic antidepressants: current trends in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry (1999): 38:517-528.
  • EMSLIE G, RUSH AJ, WEINBERG AW et al.: A double-blind, randomized, placebo controlled trial of fluoxetine in children and adolescents with depression. Arch. Gen. Psychiatry (1997) 54:1031-1037.
  • MARCH J, SILVA S, PETRYCKI S et al.: Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. J. Am. Med. Assn. (2004) 292:807-820.
  • MARCH JS, BIEDERMAN J, WOLKOW R et al.: Sertraline in children with obsessive-compulsive disorder: a multicenter randomized controlled trial. J. Am. Med. Assn. (1998) 280:1752-1756.
  • RIDDLE MA, REEVE EA, YAYURA-TOBIAS JA et al.: Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J. Am. Acad. Child Adolesc. Psychiatry (2001) 40:222-229.
  • GELLER DA, HOOG SL, HEILIGENSTEIN JH et al.: Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial. J. Am. Acad. Child Adolesc. Psychiatry (2001) 40:773-779.
  • GELLER DA, WAGNER KD, EMSLIE G et al.: Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J. Am. Acad. Child Adolesc. Psychiatry (2004) 43:1387-1396.
  • PEDIATRIC OCD TREATMENT STUDY (POTS) TEAM: Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the pediatric OCD treatment study (POTS) randomized controlled trial. J. Am. Med. Assn. (2004) 292:1969-1976.
  • RESEARCH UNIT ON PEDIATRIC PSYCHOPHARMACOLOGY (RUPP): Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N. Engl. J. Med. (2001) 344:1279-1285.
  • DILER RS, AVCI A: Selective serotonin reuptake inhibitor discontinuation syndrome in children: six case reports. Curr. Ther. Res. (2002) 63:188-197.
  • LEPOLA U, LEINONEN, E, KOPONEN H: Citalopram in the treatment of early-onset panic disorder and school-phobia. Pharmacopsychiatry (1996) 29:30-32.
  • FAIRBANKS JM, PINE DS, TANCER NK: Open fluoxetine treatment of mixed anxiety disorders in children and adolescents. J. Child Adolesc. Psychopharmacol. (1997) 7:17-29.
  • RENAUD J, BIRMAHER B, WASSICK SC, BRIDGE J: Use of selective serotonin reuptake inhibitors for the treatment of childhood panic disorder: a pilot study. J. Child Adolesc. Psychopharmacol. (1999) 9:73-83.
  • SAREEN J, COX BJ, AFIFI TO et al.: Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults. Arch. Gen. Psychiatry (2005) 62:1249-1257.
  • WHITTINGTON CJ, KENDALL T, FONAGY P et al.: Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet (2004) 363:1341-1345.
  • BRUCE SE, VASILE RG, GOISMAN RM et al.: Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? Am. J. Psychiatry (2003) 160:1432-8.
  • KUTCHER SP, MACKENZIE S: Successful clonazepam treatment of adolescents with panic disorder. J. Clin. Psychopharmacol. (1988) 8:299-301.
  • KUTCHER SP, REITER S, GARDNER DM, KLEIN RG: The pharmacotherapy of anxiety disorders in children and adolescents. Psychiatr. Clin. North Am. (1992) 15:41-67.
  • HAZELL P, O’CONNELL D, HEATHCOTE D, HENRY D: Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst. Rev. (2002) 2:CD002317.
  • HERSKOWITZ J: Neurological presentations of panic disorder in childhood and adolescence. Dev. Med. Child Neurol. (1986) 28:617-623.
  • BALLENGER JC, CAREK DJ, STEELE DJ, CORNISH-MCTIGHE D: Three cases of panic disorder with agoraphobia in children. Am. J. Psychiatry (1989) 146:922-924.
  • BLACK B, ROBBINS DR: Panic disorder in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry (1990) 29:36-44.
  • GARLAND EJ, SMITH DH: Simultaneous prepubertal onset of panic disorder, night terrors and somnambulism. J. Am. Acad. Child Adolesc. Psychiatry (1991) 30:553-555.
  • GELLER B, REISING D, LEONARD HL, RIDDLE MA, WALSH BT: Critical review of tricyclic antidepressants: current trends in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry (1999) 38:513-516.
  • BRADWEJN J, AHOKAS A, STEIN DJ et al.: Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study. Br. J. Psychiatry (2005) 187:352-359.
  • THASE ME: Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J. Clin. Psychiatry (1998) 59:502-508.
  • CASAT CD, ROSS BA, SCARDINA R et al.: Separation anxiety and mitral valve prolapse in a 12 year old girl. J. Am. Acad. Child Adolesc. Psychiatry (1987) 26:444-446.
  • BALLENGER JC, WHEADON DE, STEINER M et al.: Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am. J. Psychiatry (1998) 155:36-42.
  • CATALANO G, HAKALA SM, CATALANO MC: Sertraline-induced panic attacks. Clin. Neuropharmacol. (2000) 23:164-168.
  • EMSLIE G, HEILINGSTEIN JH, WAGNER KD et al.: Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled randomized clinical trial. J. Am. Acad. Child Adolesc. Psychiatry (2001) 41:1205-1215.
  • KECK PE, STRAWN JR, MCELROY SL: Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders. J. Clin. Psychiatry (2006) 67(Suppl.1):8-15.
  • MASI G: Prepubertal bipolar disorder: available pharmacological treatment options. Expert Opin. Pharmacother. (2005) 6:547-560.
  • PANDE AC, POLLACK MH, CROCKATT J et al.: Placebo-controlled study of gabapentin treatment of panic disorder. J. Clin. Psychopharmacol. (2000) 20:467-471

Website

  • http://www.fda.gov/ohrms/dockets/ac/04/slides/2004-4065S1_08_FDA-Hammad_files/frame.htm Results of the analysis of suicidality in pediatric trials of newer antidepressants. Presentation at the Food and Drug Administration, Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee (2004). An important survey of the risk of suicidality in children and adolescents treated with selective serotonin re-uptake inhibitors.
  • http://medicinesauthority.gov.mt/pub/12891805en.pdf EUROPEANS MEDICINES AGENCY: European Medicines Agency finalises review of antidepressants in children and adolescents. Doc. Ref. EMEA/CHMP/128918. London (25 April 2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.